Skip to main content
Piro Lito, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

PiroLitoMDPhD

Oncology • New York, NY

Associate Member, Human Oncology and Pathogenesis Program; Associate Attending, Department of Medicine; Memorial Sloan Kettering Cancer Center

Request Appointment

Overview of Dr. Lito

Dr. Piro Lito is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Michigan State University College of Human Medicine and has been in practice 9 years. He is one of 464 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 30 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2014
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2008 - 2010
  • Michigan State University College of Human Medicine
    Michigan State University College of Human MedicineClass of 2008

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2010 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Seldin Smith Award for Pioneering Research The American Society for Clinical Investigation, 2022
  • Pershing Square Sohn Prize Pershing Square Sohn Cancer Research Alliance, 2022
  • Life Sciences Breakthroughs of the Year Falling Walls Foundation, 2022
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Frontier Medicines Announces Renowned Physician Scientist Piro Lito, M.D., Ph.D., Joins Scientific Advisory Board
    Frontier Medicines Announces Renowned Physician Scientist Piro Lito, M.D., Ph.D., Joins Scientific Advisory BoardFebruary 8th, 2022
  • Mission Bio's Tapestri Platform Helps Elucidate Resistance Mechanisms to Lung Cancer Drugs in Nature Publication
    Mission Bio's Tapestri Platform Helps Elucidate Resistance Mechanisms to Lung Cancer Drugs in Nature PublicationNovember 23rd, 2021
  • Giving Drugs Together — Rather Than in Sequence — May Be Key to Halting Tumor Resistance
    Giving Drugs Together — Rather Than in Sequence — May Be Key to Halting Tumor ResistanceJuly 27th, 2017
  • Join now to see all

Hospital Affiliations

Dr. Piro Lito, Dr. Piro Lito, MD, Dr. P Lito